473 related articles for article (PubMed ID: 17274851)
1. Leishmania vaccines: progress and problems.
Kedzierski L; Zhu Y; Handman E
Parasitology; 2006; 133 Suppl():S87-112. PubMed ID: 17274851
[TBL] [Abstract][Full Text] [Related]
2. Progress towards a Leishmania vaccine.
Tabbara KS
Saudi Med J; 2006 Jul; 27(7):942-50. PubMed ID: 16830009
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous leishmaniasis: progress towards a vaccine.
Launois P; Tacchini-Cottier F; Kieny MP
Expert Rev Vaccines; 2008 Oct; 7(8):1277-87. PubMed ID: 18844599
[TBL] [Abstract][Full Text] [Related]
4. Leishmaniasis.
Kedzierski L
Hum Vaccin; 2011 Nov; 7(11):1204-14. PubMed ID: 22048116
[TBL] [Abstract][Full Text] [Related]
5. Second-generation vaccines against leishmaniasis.
Coler RN; Reed SG
Trends Parasitol; 2005 May; 21(5):244-9. PubMed ID: 15837614
[TBL] [Abstract][Full Text] [Related]
6. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora.
Innes EA; Vermeulen AN
Parasitology; 2006; 133 Suppl():S145-68. PubMed ID: 17274844
[TBL] [Abstract][Full Text] [Related]
7. Vaccines in leishmaniasis: advances in the last five years.
Brodskyn C; de Oliveira CI; Barral A; Barral-Netto M
Expert Rev Vaccines; 2003 Oct; 2(5):705-17. PubMed ID: 14711330
[TBL] [Abstract][Full Text] [Related]
8. The immunology of Leishmania infection and the implications for vaccine development.
Vanloubbeeck Y; Jones DE
Ann N Y Acad Sci; 2004 Oct; 1026():267-72. PubMed ID: 15604504
[TBL] [Abstract][Full Text] [Related]
9. Live attenuated Leishmania vaccines: a potential strategic alternative.
Silvestre R; Cordeiro-da-Silva A; Ouaissi A
Arch Immunol Ther Exp (Warsz); 2008; 56(2):123-6. PubMed ID: 18373245
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in vaccines for leishmaniasis.
Requena JM; Iborra S; Carrión J; Alonso C; Soto M
Expert Opin Biol Ther; 2004 Sep; 4(9):1505-17. PubMed ID: 15335317
[TBL] [Abstract][Full Text] [Related]
11. Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era.
Dumonteil E
Infect Genet Evol; 2009 Dec; 9(6):1075-82. PubMed ID: 19805015
[TBL] [Abstract][Full Text] [Related]
12. Genetically modified live attenuated parasites as vaccines for leishmaniasis.
Selvapandiyan A; Duncan R; Debrabant A; Lee N; Sreenivas G; Salotra P; Nakhasi HL
Indian J Med Res; 2006 Mar; 123(3):455-66. PubMed ID: 16778323
[TBL] [Abstract][Full Text] [Related]
13. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
[TBL] [Abstract][Full Text] [Related]
14. Vaccine candidates for leishmaniasis: a review.
Nagill R; Kaur S
Int Immunopharmacol; 2011 Oct; 11(10):1464-88. PubMed ID: 21616175
[TBL] [Abstract][Full Text] [Related]
15. Leishmania manipulates sandfly feeding to enhance its transmission.
Ready PD
Trends Parasitol; 2008 Apr; 24(4):151-3. PubMed ID: 18314394
[TBL] [Abstract][Full Text] [Related]
16. Current status and perspectives of the immunotherapy of leishmaniasis.
El-On J
Isr Med Assoc J; 2009 Oct; 11(10):623-8. PubMed ID: 20077951
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for leishmaniasis in the fore coming 25 years.
Palatnik-de-Sousa CB
Vaccine; 2008 Mar; 26(14):1709-24. PubMed ID: 18295939
[TBL] [Abstract][Full Text] [Related]
18. Development of vaccines against leishmaniasis.
Modabber F
Scand J Infect Dis Suppl; 1990; 76():72-8. PubMed ID: 2102023
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in antileishmanial drug development.
Davis AJ; Kedzierski L
Curr Opin Investig Drugs; 2005 Feb; 6(2):163-9. PubMed ID: 15751739
[TBL] [Abstract][Full Text] [Related]
20. Progress on vaccines against parasites.
Engers HD; Bergquist R; Modabber F
Dev Biol Stand; 1996; 87():73-84. PubMed ID: 8854004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
